Site Therapeutics Revenue
Biotechnology Research • • 11-20 Employees
Site Therapeutics revenue & valuation
| Annual revenue | $1,454,435 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,700,000 |
| Total funding | No funding |
Key Contact at Site Therapeutics
Hart Rardin
Associate Director
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Employees | 11-20 |
Site Therapeutics Email Formats
Site Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About Site Therapeutics
Site Therapeutics aims to map—down to the nucleotide—the genetic determinants driving immune cell function in human health and disease. Leveraging technology developed in the Marson Lab at UCSF/Gladstone, we will conduct high-throughput functional genomics in human cells to build a blueprint for fine-tuned control of immune cell function. This detailed map will lead to the development of new therapeutics across modalities for a range of immune-related conditions. We are backed by The Column Group, a leading life sciences venture capital firm.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Site Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Site Therapeutics has never raised funding before.
Switzerland
Finland
Frequently asked questions
4.8
40,000 users
